Barnes Peter J
Airway Disease Section, National Heart and Lung Institute, Imperial College London, Dovehouse Street, London SW3 6LY, UK.
Nat Rev Immunol. 2008 Mar;8(3):183-92. doi: 10.1038/nri2254. Epub 2008 Feb 15.
Asthma and chronic obstructive pulmonary disease (COPD) are both obstructive airway diseases that involve chronic inflammation of the respiratory tract, but the type of inflammation is markedly different between these diseases, with different patterns of inflammatory cells and mediators being involved. As described in this Review, these inflammatory profiles are largely determined by the involvement of different immune cells, which orchestrate the recruitment and activation of inflammatory cells that drive the distinct patterns of structural changes in these diseases. However, it is now becoming clear that the distinction between these diseases becomes blurred in patients with severe asthma, in asthmatic subjects who smoke and during acute exacerbations. This has important implications for the development of new therapies.
哮喘和慢性阻塞性肺疾病(COPD)均为阻塞性气道疾病,涉及呼吸道的慢性炎症,但这些疾病之间的炎症类型明显不同,涉及不同模式的炎症细胞和介质。如本综述所述,这些炎症特征在很大程度上由不同免疫细胞的参与所决定,这些免疫细胞协调驱动这些疾病中不同结构变化模式的炎症细胞的募集和激活。然而,现在越来越清楚的是,在重度哮喘患者、吸烟的哮喘患者以及急性加重期间,这些疾病之间的区别变得模糊不清。这对新疗法的开发具有重要意义。